Lexaria Bioscience (LEXX) Asset Utilization Ratio (2018 - 2026)

Lexaria Bioscience has disclosed Asset Utilization Ratio across 9 years of filings, most recently posting 0.06 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.06, up 3.08% year-over-year; the trailing twelve-month figure through Feb 2026 was 0.06 (up 3.08% YoY), and the FY2025 annual result was 0.11, up 39.33% from the prior year.
• Asset Utilization Ratio came in at 0.06 for Q1 2026 at Lexaria Bioscience, down from 0.1 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 4.13 in Q1 2024 to a low of 0.03 in Q3 2022.
• The 5-year median for Asset Utilization Ratio is 0.1 (2025), against an average of 0.43.
• Across the five-year window, Asset Utilization Ratio surged 834.48% in 2024 and plunged 98.62% in 2025, its largest moves.
• Lexaria Bioscience's Asset Utilization Ratio stood at 0.09 in 2022, then soared by 85.96% to 0.17 in 2023, then plunged by 69.38% to 0.05 in 2024, then soared by 91.7% to 0.1 in 2025, then slumped by 42.5% to 0.06 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.06 (Q1 2026), 0.1 (Q4 2025), and 0.13 (Q3 2025), per Business Quant data.